Stay up to date with the latest news and announcements from NASCSA.
On April 11, 2022, the Drug Enforcement Administration (DEA) will publish a Final Rule in the Federal Register to amend its regulations to require all new and renewal applications for DEA registration to be submitted only through a secure online portal. The Rule becomes effective 30 days after publication. A copy of an advance copy is attached.
DEA registration applications affected by this change include DEA Forms 224, 224a, 225, 225a, 363, 363a, 510, and 510a.
The Final Rule (found here) follows a Notice of Proposed Rulemaking (NPRM) published on January 7, 2021. Four comments were received to the proposal. The Rule was finalized as proposed with the exception that DEA is clarifying that Automated Clearing House (ACH) fund transfers will be accepted as payment for registrations and renewals.
The basis for this change was stated ?to modernize DEA?s approach to registration and renewal applications. The proposed changes require online submission and eliminate inefficient paper applications. Typographical errors or missing pieces of information routinely resulted in delayed or rejected applications. DEA has determined the online application process will prove more efficient and effective for both DEA and registrants.?
For those companies that submit multiple applications, DEA has determined that batch processing remains supported by existing regulations.
RxGov by Tyler Technologies
RxGov is a leading Prescription Monitoring Platform (PMP) that improves access to clinical data pertinent to a patient's medication history and the risk factors associated with substance use disorder through the capture, analysis, proactive monitoring, and open sharing of a state's prescription dispense details.
The system is one of the most interoperable, integrated and intuitive on the market. It also includes complete oversight and compliance with the state's current PDMP system, including statewide mandates. RxGov allows the PDMP administrator unprecedented access to insightful data sets, such as query history and compliance reports at all levels: state, region, organization, and individual prescriber. Freely accessible data, enhanced by useful visualization tools, is central to RxGov.
To learn more about RxGov and how the platform can help state governments fight the opioid crisis, email firstname.lastname@example.org or download our one pager.